Vaxcyte Inc. (PCVX)
84.41
6.27 (8.02%)
At close: Jan 15, 2025, 11:42 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -402.27M | -223.49M | -100.08M | -89.22M | -50.27M | -29.48M | -17.24K |
| Depreciation & Amortization | 10.17M | 9.20M | 3.46M | 1.41M | 1.23M | 1.04M | 625.00 |
| Stock-Based Compensation | 48.76M | 23.65M | 10.73M | 5.43M | 1.19M | 749.00K | 390.00 |
| Other Working Capital | 70.09M | 9.84M | -24.54M | 9.17M | -698.00K | 550.00K | 1K |
| Other Non-Cash Items | -34.77M | 7.30M | 1.50M | 179.00K | -3.20M | -4.71M | 260.00 |
| Deferred Income Tax | n/a | n/a | n/a | 301.00K | 1K | 51.00K | n/a |
| Change in Working Capital | 81.32M | 12.74M | -37.01M | 35.27M | 3.91M | 1.90M | 1K |
| Operating Cash Flow | -296.79M | -170.60M | -121.39M | -46.63M | -47.15M | -30.47M | -14.96K |
| Capital Expenditures | -67.88M | -5.85M | -6.55M | -1.16M | -1.20M | -1.77M | -1.22K |
| Acquisitions | n/a | 7.00K | 26.00K | 50.00K | n/a | 1K | n/a |
| Purchase of Investments | -1.33B | -102.75M | -336.34M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 624.46M | 183.17M | 130.56M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 80.43K | -205.75K | 50.00 | n/a | 1K | 106.00 |
| Investing Cash Flow | -773.31M | 74.58M | -212.31M | -1.10M | -1.20M | -1.77M | -1.12K |
| Debt Repayment | n/a | n/a | n/a | -61.00K | -278.00K | -283.00K | -188.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.77M | 5.07M | 3.90M | 110.92M | 41.84M | 62.47M | 231.86K |
| Financial Cash Flow | 639.81M | 861.55M | 17.80M | 374.87M | 41.57M | 62.19M | 43.86K |
| Net Cash Flow | -436.97M | 765.67M | -316.34M | 327.22M | -7.11M | 29.95M | 27.78K |
| Free Cash Flow | -364.67M | -176.44M | -127.95M | -47.78M | -48.34M | -32.24M | -16.18K |